BARBANTI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 7.558
NA - Nord America 3.685
AS - Asia 520
SA - Sud America 16
AF - Africa 11
OC - Oceania 8
Totale 11.798
Nazione #
IE - Irlanda 5.755
US - Stati Uniti d'America 3.679
GB - Regno Unito 819
CH - Svizzera 405
SG - Singapore 312
FI - Finlandia 307
DE - Germania 117
IT - Italia 85
CN - Cina 73
HK - Hong Kong 63
CZ - Repubblica Ceca 32
KR - Corea 25
NL - Olanda 16
BR - Brasile 14
IR - Iran 10
TR - Turchia 8
AU - Australia 7
EG - Egitto 7
AT - Austria 5
CA - Canada 5
IN - India 5
TW - Taiwan 5
JP - Giappone 4
BE - Belgio 3
ES - Italia 3
IL - Israele 3
LV - Lettonia 3
UG - Uganda 3
AZ - Azerbaigian 2
FR - Francia 2
NP - Nepal 2
PK - Pakistan 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
KH - Cambogia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SE - Svezia 1
Totale 11.798
Città #
Dublin 5.718
London 812
Boardman 800
Ashburn 778
Santa Clara 408
Zurich 405
Helsinki 306
Washington 197
Singapore 184
Hong Kong 62
Los Angeles 54
Munich 38
Seoul 25
Brno 21
Chicago 21
Seattle 21
Milan 16
Amsterdam 12
Falkenstein 12
Shanghai 12
Catania 11
Olomouc 11
Clifton 9
Piscataway 9
Tappahannock 8
Rome 7
Tanta 7
Brasília 6
Genoa 6
Ottawa 5
North Bergen 4
São Paulo 4
Taipei 4
Berlin 3
Brussels 3
Chengdu 3
Guangzhou 3
Kampala 3
Melbourne 3
New York 3
Riga 3
Sivas 3
Turin 3
Aci Sant'Antonio 2
Alcamo 2
Baku 2
Bangkok 2
Belpasso 2
Frankfurt am Main 2
Guildford 2
Hadera 2
Karachi 2
Karlsruhe 2
Mantova 2
Marano Vicentino 2
Ningbo 2
Nuremberg 2
Pollenza 2
Rimini 2
San Francisco 2
Shenzhen 2
Spring 2
Surat 2
São José do Rio Preto 2
Tehran 2
Tokyo 2
Vittoria 2
West Jordan 2
Addis Ababa 1
Auckland 1
Aversa 1
Bardhaman 1
Beijing 1
Bochum 1
Brescia 1
Calvisano 1
Changsha 1
Chennai 1
Chongqing 1
Copenhagen 1
Dalian 1
Espoo 1
Fiorenzuola d'Arda 1
Fuyang 1
Giv‘atayim 1
Huzhou 1
Jining 1
Kathmandu 1
Kunming 1
Lima 1
Madrid 1
Magione 1
Manila 1
Meizhou 1
Mesa 1
Messina 1
Nanchang 1
Nanjing 1
Naples 1
Newark 1
Totale 10.105
Nome #
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.139
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 116
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 61
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 60
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 54
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 54
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 53
The Helio transcatheter aortic dock for patients with aortic regurgitation 52
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 51
Early detection of transcatheter heart valve dysfunction 51
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 51
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 51
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 51
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 51
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 50
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 50
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 50
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 49
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 49
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 48
Managing complications after transcatheter aortic valve implantation 48
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 48
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 48
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 48
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 48
Early discharge after transfemoral transcatheter aortic valve implantation 48
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 47
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 47
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 47
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 47
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era: A “Die-Hard” Procedure 47
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 47
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 46
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 46
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 46
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 46
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 46
Transcatheter mitral valve repair: a brief review 45
Bioprosthetic valves for transcatheter aortic valve replacement 45
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 45
Cerebral embolization during transcatheter aortic valve implantation 45
The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation 45
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 45
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 45
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 44
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 44
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 44
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 44
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 44
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 44
Protesi Percutanee Aortiche: Le indicazioni si allargano 44
Transcatheter aortic valve replacement in bicuspid aortic valve disease 44
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 44
Avoiding Coronary Occlusion and Root Rupture in TAVI – The Role of Pre-procedural Imaging and Prosthesis Selection 44
Transcatheter mitral valve implantation: CardiAQ 44
Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings 44
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 43
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 43
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 43
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 43
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 43
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 43
Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair 43
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 43
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 43
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 43
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion 43
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 42
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 42
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 42
Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients With Failing Bioprosthetic Aortic Valves: Mid-term Outcomes From the Italian CoreValve Clinical Service Project 42
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 42
Management of severe stenosis controversies and promises 42
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 42
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 42
Early Outcomes of the Evolut R Transcatheter Aortic Valve: A New Technology Between Achieved Goals and Desirable Improvements 42
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 41
How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures 41
Sinus of Valsalva Sequestration Following Transcatheter-Based Management of ACURATE neo2 Valve Embolization 41
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 41
Reduction of mitral valve regurgitation with Mitraclip® percutaneous system 41
Update on percutaneous mitral valve therapy: clinical results and real life experience 41
Response to Letter by Piriou et al Regarding Article, "Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation" 41
Severe aortic valve stenosis: Symptoms, biochemical markers, and global longitudinal strain 41
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 41
How true delivery profile diminution reduces vascular access challenges and complications 40
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation 40
Optimisation of TAVI: is it mature enough to be defined as a PCI-like procedure? 40
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 40
Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients 40
Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves 39
Transcatheter Aortic Valve Implantation Under Angiographic Guidance With and Without Adjunctive Transesophageal Echocardiography 39
Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis Patients Undergoing Chronic Dialysis 39
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation 39
Balloon-Expandable Valve for Treatment of Self-Expanding Supra-Annular Valve Failure 39
Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study 38
TAVR and Left Main Stenting: Can 2 Giants Live in Harmony in a Small Room? 38
Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata 38
Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes 38
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement 37
Totale 5.638
Categoria #
all - tutte 78.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/20253.246 1.491 249 544 152 610 200 0 0 0 0 0 0
Totale 12.206